Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 148
Filter
2.
PLoS One ; 18(1): e0279713, 2023.
Article in English | MEDLINE | ID: mdl-36662716

ABSTRACT

BACKGROUND: SARS-CoV-2 Delta variant caused a large number of COVID-19 cases in many countries, including Vietnam. Understanding mortality risk factors is crucial for the clinical management of severe COVID-19. METHODS: We conducted a retrospective study at an intensive care center in Ho Chi Minh City that urgently built by Bach Mai Hospital during the COVID-19 outbreak in Vietnam, when the Delta variant predominated. Participants were laboratory-confirmed patients with SARS-CoV-2 infection, admitted in August 2021. Data on patients' demographic and clinical characteristics, radiographic and laboratory findings, treatment, and clinical time course were compared between survivors and non-survivors. Risk factors to mortality were assessed using logistic regression. RESULTS: Among 504 eligible COVID-19 patients, case fatality was 52.2%. Unvaccinated patients accounted for 61.2% of non-survivors and 43.6% of survivors (p < 0.001). The time from onset to hospital admission was 8 days in non-survivors and 7 days in survivors (p = 0.004). Among non-survivors, 90.2% developed acute respiratory distress syndrome (ARDS). Oxygen therapy was administered for all patients, but antiviral agent was given to 51.7% of non-survivors. 54.2% of non-survivors tested positive for the bacterial infection using blood culture. The risk factors for mortality were diabetes mellitus, respiration rate, oxygen saturation, vaccination status, time from onset to admission, and older age. CONCLUSIONS: Critical patients with COVID-19 owing to the Delta variant in Vietnam had delayed hospital admission, leading to ARDS and death. Early availability of vaccines and preventing bacterial infections are crucial for reducing mortality of COVID-19, especially in low- and middle-income countries.


Subject(s)
COVID-19 , Respiratory Distress Syndrome , Humans , SARS-CoV-2 , Retrospective Studies , Critical Illness , Vietnam/epidemiology , Respiratory Distress Syndrome/therapy
3.
J Gastroenterol ; 57(10): 709-724, 2022 10.
Article in English | MEDLINE | ID: mdl-35994093

ABSTRACT

BACKGROUND: Chronic pancreatitis (CP) is defined according to the recently proposed mechanistic definition as a pathological fibro-inflammatory syndrome of the pancreas in individuals with genetic, environmental, and/or other risk factors who develop persistent pathological responses to parenchymal injury or stress. METHODS: The clinical practice guidelines for CP in Japan were revised in 2021 based on the 2019 Japanese clinical diagnostic criteria for CP, which incorporate the concept of a pathogenic fibro-inflammatory syndrome in the pancreas. In this third edition, clinical questions are reclassified into clinical questions, background questions, and future research questions. RESULTS: Based on analysis of newly accumulated evidence, the strength of evidence and recommendations for each clinical question is described in terms of treatment selection, lifestyle guidance, pain control, treatment of exocrine and endocrine insufficiency, and treatment of complications. A flowchart outlining indications, treatment selection, and policies for cases in which treatment is ineffective is provided. For pain control, pharmacological treatment and the indications and timing for endoscopic and surgical treatment have been updated in the revised edition. CONCLUSIONS: These updated guidelines provide clinicians with useful information to assist in the diagnosis and treatment of CP.


Subject(s)
Pancreatitis, Chronic , Endoscopy/adverse effects , Humans , Pain , Pancreas/pathology , Pancreatitis, Chronic/diagnosis , Pancreatitis, Chronic/etiology , Pancreatitis, Chronic/therapy , Risk Factors
5.
Article in English | MEDLINE | ID: mdl-35742596

ABSTRACT

Since the start of the COVID-19 pandemic, many healthy older adults have been less willing to engage in group exercise for fear of contracting this illness. Therefore, there is a need for an effective home-based exercise program to prevent frailty in the elderly. In this study, we assessed the effectiveness of ankle weights as a frailty prevention device for older adults. The study participants were aged 50−90 years and were screened for falls using the Motor Fitness Scale. Participants were divided into two age groups (≤70 and >70 years) for analysis. Older community-dwelling adults were invited to use ankle weights for 3 months. Seventy-four people responded to the invitation. Physical and cognitive status and performance (body composition, grip strength, standing on one leg with eyes open, the 30 s chair stand test (CS-30), Timed Up and Go test, walking speed, body sway, Japanese version of the Montreal Cognitive Assessment) were assessed before and after 3 months of intervention. CS-30 performance improved during the study. CS-30 reflects lower limb/trunk muscle strength and can be used to indicate the risk of falls. Wearing ankle weights can be recommended for strengthening the muscles of the lower limb and trunk in the elderly.


Subject(s)
COVID-19 , Frailty , Aged , Ankle , COVID-19/epidemiology , COVID-19/prevention & control , Frailty/prevention & control , Humans , Independent Living , Lower Extremity , Pandemics , Postural Balance/physiology , Time and Motion Studies
6.
J Gastroenterol ; 57(4): 225-245, 2022 04.
Article in English | MEDLINE | ID: mdl-35192048

ABSTRACT

In response to the latest knowledge and the amendment of the Japanese diagnostic criteria for autoimmune pancreatitis (AIP) in 2018, the Japanese consensus guidelines for managing AIP in 2013 were required to be revised. Three committees [the professional committee for developing clinical questions (CQs) and statements by Japanese specialists; the expert panelist committee for rating statements by the modified Delphi method; and the evaluating committee of moderators] were organized. Twenty specialists in AIP extracted the specific clinical statements from a total of 5218 articles (1963-2019) from a search in PubMed and the Cochrane Library. The professional committee made 14, 9, 5, and 11 CQs and statements for the current concept and diagnosis, extra-pancreatic lesions, differential diagnosis, and treatment, respectively. The expert panelists regarded the statements as valid after a two-round modified Delphi approach with individually rating these clinical statements, in which a clinical statement receiving a median score greater than 7 on a 9-point scale from the panel was regarded as valid. After evaluation by the moderators, the amendment of the Japanese consensus guidelines for AIP has been proposed in 2020.


Subject(s)
Autoimmune Pancreatitis , Consensus , Delphi Technique , Diagnosis, Differential , Humans , Japan
7.
Sci Rep ; 11(1): 8285, 2021 04 15.
Article in English | MEDLINE | ID: mdl-33859301

ABSTRACT

Endoscopic pancreatic stenting is used to prevent main pancreatic duct obstruction and relieve painful symptoms of chronic pancreatitis. However, the stent typically needs to be exchanged and the rate of adverse events is high. Few studies have evaluated the effect of stent shape on those outcomes. We evaluated the adverse events, stent patency, and total medical cost within 90 days of patients who received an 8.5 French (Fr) physiologically shaped pancreatic stent by comparing these features with those associated with a conventional straight-type stent for ≥ 90 days. The total stent-related adverse event rate was significantly lower for the physiologically shaped pancreatic stent (physiologically shaped, 6.7% [2/30]; straight-type, 50.6% [44/87]; P < 0.001). Stent occlusion was significantly less frequent (P < 0.001) and the total medical costs were significantly lower (P = 0.002) for the physiologically shaped stent. The stent-related adverse event rate was significantly higher for the 10 Fr straight type stent than for the 8.5 Fr physiologically shaped stent (10 Fr, straight-type vs. 8.5 Fr, physiologically shaped: 36.1% [13/36] vs. 6.7% [2/30]; P = 0.007). In conclusion, a physiologically shaped pancreatic stent was superior to a straight-type stent in terms of the patency rate and medical costs.


Subject(s)
Endoscopy, Digestive System/methods , Pancreatitis, Chronic/surgery , Prosthesis Design , Stents , Adult , Aged , Aged, 80 and over , Constriction, Pathologic/prevention & control , Endoscopy, Digestive System/adverse effects , Female , Humans , Male , Middle Aged , Pain/etiology , Pain/prevention & control , Pancreatic Ducts/pathology , Pancreatitis, Chronic/complications , Prosthesis Failure/etiology , Stents/adverse effects , Stents/economics , Treatment Outcome
8.
J Hepatobiliary Pancreat Sci ; 28(3): 235-242, 2021 Mar.
Article in English | MEDLINE | ID: mdl-33586343

ABSTRACT

Several years have passed since the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012 were published. New findings and knowledge have accumulated since then. The Research Committees for IgG4-related Diseases and for Intractable Diseases of the Liver and Biliary Tract, in association with the Ministry of Health, Labor, and Welfare of Japan and the Japan Biliary Association, have established a working group consisting of researchers specializing in IgG4-SC and have drawn up new clinical diagnostic criteria for IgG4-SC 2020. The diagnosis of IgG4-SC is based on a combination of the following six criteria: (a) narrowing of the intra- or extrahepatic bile duct; (b) thickening of the bile duct wall; (c) serological findings; (d) pathological findings; (e) other organ involvement; and (f) effectiveness of steroid therapy. These new diagnostic criteria for IgG4-SC are useful in practice for general physicians and other non-specialists.


Subject(s)
Bile Ducts, Extrahepatic , Biliary Tract , Cholangitis, Sclerosing , Cholangitis, Sclerosing/diagnosis , Diagnosis, Differential , Humans , Immunoglobulin G , Liver
9.
Biochem Cell Biol ; 99(1): 159-165, 2021 02.
Article in English | MEDLINE | ID: mdl-32905707

ABSTRACT

Patients with ulcerative colitis or colonic Crohn's disease have a significantly increased risk of developing colorectal cancer. Bovine lactoferrin (bLF) reportedly inhibited the development of colon cancer in rats and mice, and in a placebo controlled trial, ingestion of bLF inhibited the growth of intestinal polyps. In addition, in a case study, a patient with Crohn's disease was reported to have remained in remission for over 7 years while ingesting 1 g of bLF daily. Thus, bLF has an inhibitory effect on colon carcinogenesis, and it may also promote remission of Crohn's disease. The purpose of this study was to investigate the effects of bLF in a mouse model of colorectal cancer related to irritable bowel disease (IBD). The mice were divided into 4 groups: (i) no treatment; (ii) treated with bLF only; (iii) treated with azoxymethane plus dextran sulfate sodium (AOM + DSS); and (iv) treated with AOM + DSS + bLF. AOM was used to initiate intestinal cancer, and DSS was used to induce IBD-like inflammation in the intestine of the C57BL/6 mice. At the end of the study, the mice treated with AOM + DSS + bLF had a better fecal score, fewer lesions in the colon, and less weight loss than the mice treated with AOM + DSS without bLF. However, there were no statistically significant differences between the two groups with respect to tumor burden.


Subject(s)
Antineoplastic Agents/pharmacology , Colonic Neoplasms/drug therapy , Crohn Disease/drug therapy , Disease Models, Animal , Inflammation/drug therapy , Lactoferrin/metabolism , Administration, Oral , Animals , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/metabolism , Cattle , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Crohn Disease/metabolism , Crohn Disease/pathology , Inflammation/metabolism , Inflammation/pathology , Lactoferrin/administration & dosage , Male , Mice , Mice, Inbred C57BL
10.
Intern Med ; 60(1): 47-52, 2021 Jan 01.
Article in English | MEDLINE | ID: mdl-32893228

ABSTRACT

An 84-year-old man was admitted with epigastralgia. Computed tomography showed contrast-enhanced wall thickness in the cystic duct. An endoscopic examination revealed short irregular stricture in the cystic duct, and per-oral cholangioscopy revealed a reddish papillary tumor at the stricture site. Surgical resection revealed high-grade biliary intraepithelial neoplasia (BilIN) at the stricture site of the cystic duct. To our knowledge, this is the first case of a solitary high-grade BilIN epithelium in the cystic duct detected by per-oral cholangioscopy.


Subject(s)
Bile Duct Neoplasms , Carcinoma in Situ , Aged, 80 and over , Bile Duct Neoplasms/diagnostic imaging , Bile Duct Neoplasms/surgery , Bile Pigments , Carcinoma in Situ/diagnostic imaging , Carcinoma in Situ/surgery , Cystic Duct/diagnostic imaging , Humans , Male , Tomography, X-Ray Computed
11.
PLoS One ; 15(8): e0237104, 2020.
Article in English | MEDLINE | ID: mdl-32750083

ABSTRACT

BACKGROUND: Vitamins and minerals are routinely administered by total parenteral nutrition (TPN). However, in Japan, adjustments in iron dosage are difficult because blended mineral preparations are often used. It is therefore unclear whether the iron content is appropriate in cases of long-term TPN. The aim of the study was to assess the influence of iron administration by long-term TPN on iron deposition in post-mortem liver samples isolated from older deceased patients. METHODS: Liver tissues were collected from post-mortem autopsies of 187 patients over a period of 15 years. Samples were stained with Prussian blue and histologically evaluated from Grade 0-V by at least three different observers. Specimens with positive and negative iron staining were compared, and positive samples were grouped according to the level and distribution of the staining. Post-mortem blood obtained from the subclavian vein during autopsy was also analysed. Samples were collected for the measurement of unsaturated serum iron, serum iron, albumin, prealbumin, hepcidin, and IL-6 concentrations. RESULTS: Iron accumulation in the liver was significantly higher in male patients (p = 0.005) with a history of surgery (p = 0.044) or central vein administration of iron (p<0.001). Additionally, the duration of TPN in the iron-positive group was significantly longer than in the iron-negative group (p = 0.038). Serum analysis revealed that unsaturated serum iron was significantly higher in the iron-negative group and that ferritin and serum iron were significantly higher in the iron-positive group. No other statistically significant differences were observed between the two groups. CONCLUSIONS: Chronic intravenous administration of iron was associated with iron deposition in the liver, even when given the minimum recommended dosage. In long-term TPN patients, the iron dose should therefore be carefully considered.


Subject(s)
Iron/administration & dosage , Liver/metabolism , Aged , Aged, 80 and over , Autopsy , Female , Humans , Infusions, Intravenous , Iron/blood , Iron/metabolism , Liver/pathology , Male , Parenteral Nutrition
15.
Intern Med ; 58(21): 3087-3092, 2019 Nov 01.
Article in English | MEDLINE | ID: mdl-31292382

ABSTRACT

A 70-year-old man was admitted to our hospital due to elevated levels of hepatobiliary and pancreatic enzymes. Computed tomography showed contrast-enhanced mucosal hypertrophy from the duodenal papilla to the distal bile duct. Endoscopic examinations revealed a laterally spreading granular tumor and ampullary swelling. After surgical resection, an examination revealed well-differentiated adenocarcinoma of the ampulla with tubular adenoma spreading from the distal common bile duct to the second part of the duodenum showing both bile duct and duodenal phenotypes. To our knowledge, this is the first case of a tumor spreading from the bile duct to the duodenum that exhibited multiple phenotypes.


Subject(s)
Adenocarcinoma/pathology , Adenoma/pathology , Common Bile Duct Neoplasms/pathology , Duodenal Neoplasms/pathology , Neoplasms, Multiple Primary/pathology , Adenocarcinoma/surgery , Adenoma/surgery , Aged , Ampulla of Vater , Common Bile Duct/diagnostic imaging , Common Bile Duct/pathology , Common Bile Duct Neoplasms/surgery , Duodenal Neoplasms/diagnostic imaging , Duodenal Neoplasms/surgery , Duodenum/diagnostic imaging , Duodenum/pathology , Humans , Male , Neoplasm Invasiveness , Neoplasms, Multiple Primary/surgery , Tomography, X-Ray Computed
16.
Nihon Ronen Igakkai Zasshi ; 56(2): 171-180, 2019.
Article in Japanese | MEDLINE | ID: mdl-31092783

ABSTRACT

AIM: The effect of polypharmacy on the surviral-time in patients with dementia has never been fully elucidated. METHODS: A retrospective study was conducted in a hospital in Aichi, Japan, by reviewing the medical charts and autopsy reports. Patients were hospitalized and neuropathologically diagnosed with dementia. The data on medication was collected from the prescribed drugs taking right before the admission. Patients were divided into two groups according to the number of prescribed drugs: ≥ 5 drugs (polypharmacy) vs. ≤ 4 drugs (non-polypharmacy). "Drugs to be prescribed with special caution" were defined in accordance with the guidelines for medical treatment and its safety in the elderly (2015). RESULTS: Seventy-six patients were eligible, and 39.5% of patients had polypharmacy. The Kaplan-Meier method showed that the polypharmacy group tended to have a shorter survival-time than the non-polypharmacy group (p=0.067). A Cox proportional hazard model showed that the polypharmacy group tended to have a higher risk for a reduced survival-time than the non-polypharmacy group, and this tendency was more prominent after adjusting for sex and age at admission (adjusted hazard ratio, 1.631; 95% confidence interval, 0.991-2.683; p=0.054). "Drugs to be prescribed with special caution", including hypnotic-sedative drugs, antianxiety drugs, antipsychotics, and benzodiazepines, were not found to be risk factors for a reduced survival-time. CONCLUSIONS: The present study showed that polypharmacy in terminal patients with dementia tended to carry a risk for reducing their remaining lifespan. The results warrant further additional study.


Subject(s)
Antipsychotic Agents , Dementia , Polypharmacy , Aged , Antipsychotic Agents/therapeutic use , Humans , Japan , Retrospective Studies
17.
Pancreas ; 48(1): 49-54, 2019 01.
Article in English | MEDLINE | ID: mdl-30540679

ABSTRACT

OBJECTIVE: Autoimmune pancreatitis (AIP) has the potential to transform into chronic pancreatitis with pancreatic stone involvement. This retrospective investigation sought to clarify the risk factors for stone formation in type 1 AIP. METHODS: Questionnaires on patients with type 1 AIP were sent to 22 high-volume medical centers across Japan to compare the clinical features of patients with and without pancreatic stone formation. RESULTS: Of the completed records on 624 type 1 AIP patients, 31 (5%) had experienced pancreatic stones. Median follow-up duration was 1853 days. Bentiromide test values at diagnosis were significantly lower, and hemoglobin A1c values after corticosteroid treatment were significantly higher in patients with pancreatic stones. Imaging results disclosed that pancreatic atrophy and hilar or intrahepatic bile duct stenosis were significantly more frequent in patients with pancreatic stone formation. Pancreatic head swelling tended to be more frequent in this group as well. On the other hand, a shorter follow-up period was associated with the nonformation of pancreatic stones. CONCLUSIONS: The increased frequency of pancreatic head swelling in type 1 AIP patients exhibiting pancreatic stones indicated a propensity for pancreatic juice stasis with subsequent stone development and pancreatic dysfunction occurring over longer periods of disease duration.


Subject(s)
Autoimmune Diseases/pathology , Calculi/complications , Pancreatic Diseases/complications , Pancreatitis, Chronic/pathology , Pancreatitis/pathology , Adolescent , Adult , Aged , Aged, 80 and over , Autoimmune Diseases/complications , Disease Progression , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Pancreatitis/complications , Propensity Score , Retrospective Studies , Risk Factors , Young Adult
18.
J Hepatobiliary Pancreat Sci ; 26(1): 9-42, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30575336

ABSTRACT

IgG4-related sclerosing cholangitis (IgG4-SC) is a distinct type of cholangitis frequently associated with autoimmune pancreatitis and currently recognized as a biliary manifestation of IgG4-related disease. Although clinical diagnostic criteria of IgG4-SC were established in 2012, differential diagnosis from primary sclerosing cholangitis and cholangiocarcinoma is sometimes difficult. Furthermore, no practical guidelines for IgG4-SC are available. Because the evidence level of most articles retrieved through searching the PubMed, Cochrane Library, and Igaku Chuo Zasshi databases was below C based on the systematic review evaluation system of clinical practice guidelines MINDS 2014, we developed consensus guidelines using the modified Delphi approach. Three committees (a guideline creating committee, an expert panelist committee for rating statements according to the modified Delphi method, and an evaluating committee) were organized. Eighteen clinical questions (CQs) with clinical statements were developed regarding diagnosis (14 CQs) and treatment (4 CQs). Recommendation levels for clinical statements were set using the modified Delphi approach. The guidelines explain methods for accurate diagnosis, and safe and appropriate treatment of IgG4-SC.


Subject(s)
Cholangitis, Sclerosing/diagnosis , Immunoglobulin G/immunology , Algorithms , Autoimmune Diseases/diagnosis , Autoimmune Diseases/immunology , Cholangitis, Sclerosing/classification , Cholangitis, Sclerosing/complications , Cholangitis, Sclerosing/therapy , Delphi Technique , Humans
19.
Nihon Ronen Igakkai Zasshi ; 55(3): 358-366, 2018.
Article in Japanese | MEDLINE | ID: mdl-30122702

ABSTRACT

AIM: Awareness reform aims to enable survival in an aging society, and ultimately, improve healthcare. An ideal way to achieve this is by implementing Advance directive (Ad) and Advance Care Planning (ACP), which do not usually include postmortem events. This study aims to create opportunities for Ad and ACP to include the postmortem period as a trigger for this awareness reform. METHODS: We conducted an Ad/ACP enlightenment lecture, and a questionnaire survey pre- and post-lecture for the elderly in old New Town, which is known for its aging society. The questionnaire comprised 38 multiple-choice questions covering 6 themes assuming an advanced state of dementia. RESULTS: There were 35 participants (7 men and 22 women) aged 40-89 years. Several people left during the lecture, making it difficult to capture the precise transformation effect with regard to changing of mind. However, the effect of enlightenment was identified as a result of the consciousness survey. A statistically significant change in consciousness occurred in response to social contribution after death. Furthermore, notably more people wanted emergency transportation compared to those wanting resuscitation and extension of life. CONCLUSIONS: The medical treatment desired might vary over time. Even the desire for life extension may differ significantly among individuals. This survey indicated a divergent view between the general public and medical staff, regarding a series of medical actions. We must persistently promote opportunities for enlightenment in cooperation with the general public (i.e., the communities and families we serve).


Subject(s)
Advance Care Planning , Patient Education as Topic , Adult , Advance Directives , Aged , Aged, 80 and over , Directed Tissue Donation , Female , Health Records, Personal , Humans , Male , Middle Aged , Surveys and Questionnaires
20.
Pancreas ; 47(6): 708-714, 2018 07.
Article in English | MEDLINE | ID: mdl-29851750

ABSTRACT

OBJECTIVES: The aim of this study was to assess prevailing treatment of pancreatolithiasis in Japan. METHODS: We surveyed clinical data from 1834 patients (1479 men and 355 women) at 125 hospitals. RESULTS: Extracorporeal shock-wave lithotripsy (ESWL) was performed alone in 103 patients (5.6%), ESWL plus an endoscopic procedure in 446 (24.3%), endoscopic treatment alone in 261 (14.2%), and surgery in 167 (9.1%). Other treatments were given to 358 (19.5%), whereas 499 (27.2%) received no treatment. Symptoms were relieved in 85.7% after ESWL, 80.8% after endoscopic treatment alone, and 92.8% after surgery. Early complication rates within 3 months after ESWL, endoscopic treatment alone, and surgery were 8%, 4.5%, and 27.1%, respectively. Late complications after ESWL, endoscopic procedures alone, and surgery were 1.7%, 2.5%, and 8.2%, respectively. Symptom relief but also early and late complications were greater after surgery than after ESWL and endoscopic treatment. Among 417 patients undergoing ESWL, 61 (14.6%) required surgery, as did 32 (16%) of 200 patients treated endoscopically. Surgery was required less frequently following initial operative treatment (11/164 patients [6.7%]). Nonsurgical initial treatments were chosen more frequently. CONCLUSIONS: First-line treatment of pancreatolithiasis should be ESWL with or without endoscopy because of minimal invasiveness and fewer complications.


Subject(s)
Health Surveys/methods , Lithiasis/therapy , Lithotripsy/methods , Pancreatic Diseases/therapy , Adolescent , Adult , Aged , Aged, 80 and over , Asian People , Child , Combined Modality Therapy , Endoscopy/methods , Female , Health Surveys/statistics & numerical data , Humans , Japan , Lithiasis/ethnology , Lithiasis/surgery , Male , Middle Aged , Pancreatic Diseases/ethnology , Pancreatic Diseases/surgery , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...